Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 20.60
Change Today +0.10 / 0.49%
Volume 1.6M
INSL On Other Exchanges
Symbol
Exchange
OTC US
Tel Aviv
Tel Aviv
Tel Aviv
As of 10:24 AM 05/26/15 All times are local (Market data is delayed by at least 15 minutes).

insuline medical ltd (INSL) Snapshot

Open
$20.50
Previous Close
$20.50
Day High
$20.80
Day Low
$20.30
52 Week High
05/26/14 - $229.00
52 Week Low
04/20/15 - $19.60
Market Cap
33.8M
Average Volume 10 Days
2.2M
EPS TTM
$-0.41
Shares Outstanding
164.1M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for INSULINE MEDICAL LTD (INSL)

Related News

No related news articles were found.

insuline medical ltd (INSL) Related Businessweek News

No Related Businessweek News Found

insuline medical ltd (INSL) Details

Insuline Medical ltd. manufactures and markets medical devices in Israel. Its medical devices enable patients on intensive insulin therapy to take control of their disease and reach treatment targets. The company primarily offers InsuPad, a non-invasive medical device designed for type 1 and 2 diabetes. It also operates online stores. The company is based in Petah Tikva, Israel.

insuline medical ltd (INSL) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

insuline medical ltd (INSL) Key Developments

InsuLine Medical Ltd. expected to report Q1 2015 results on May 26, 2015. This event was calculated by Capital IQ (Created on April 14, 2015).

InsuLine Medical Ltd. expected to report Q1 2015 results on May 26, 2015. This event was calculated by Capital IQ (Created on April 14, 2015).

InsuLine Medical Ltd. Signs Memorandum of Understanding with Johnson and Johnson

InsuLine Medical Ltd. is attracting a great deal of attention after the company reported it had signed a memorandum of understanding with Johnson and Johnson. Under the memorandum of understanding, InsuLine and Johnson and Johnson will cooperate immediately in obtaining regulatory approval for marketing InsuPad, which reduces injected insulin uptake speed in diabetics by near 50%. Johnson and Johnson will also manage registration procedures with the various authorities. Once regulatory approval for marketing is obtained, the parties will negotiate a final binding distribution agreement for each territory, in which Johnson and Johnson will be the sole distributor. In addition to Russia, the agreement will also include Ukraine and other former Soviet Union countries Belarus, Armenia, Azerbaijan, Georgia, Kazakhstan, Kirgizstan, Moldova, Tajikistan, Turkmenistan, and Uzbekistan. The registration procedure is likely to take a year.

Insuline Medical Appoints Jacob Harel to its Board of Directors

Insuline Medical has announced the appointment of Mr. Jacob Harel to its Board of Directors. Mr. Harel has over 27 years of experience in sales, marketing, operation and business development in senior executive positions in the pharmaceutical industry.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INSL:IT 20.60 +0.10

INSL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for INSL.
View Industry Companies
 

Industry Analysis

INSL

Industry Average

Valuation INSL Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INSULINE MEDICAL LTD, please visit www.insuline-medical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.